ESTIMATION OF LIVER IRON CONCENTRATION BY SERUM FERRITIN MEASUREMENT IN NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS: ANALYSIS FROM THE 1-YEAR THALASSA STUDY

被引：0
|
作者：
Taher, A. [1 ]
Porter, J. [2 ]
Viprakasit, V. [3 ]
Kattamis, A. [4 ]
Chuncharunee, S. [5 ]
Sutcharitchan, P. [6 ,7 ]
Siritanaratkul, N. [3 ]
Galanello, R. [8 ]
Karakas, Z. [9 ]
Lawniczek, T. [10 ]
Habr, D. [11 ]
Ros, J. [10 ]
Zhang, Y. [11 ]
Cappellini, D. [12 ]
机构：
[1] Amer Univ Beirut, Beirut, Lebanon
[2] UCL, London, England
[3] Mahidol Univ, Siriraj Hosp, Bangkok, Thailand
[4] Univ Athens, Dept Pediat 1, Athens, Greece
[5] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand
[6] Chulalongkorn Univ, Bangkok, Thailand
[7] King Chulalongkorn Mem Hosp, Bangkok, Thailand
[8] Univ Cagliari, Osped Reg Microcitemie, Cagliari, Italy
[9] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey
[10] Novartis Pharma AG, Basel, Switzerland
[11] Novartis Pharmaceut, E Hanover, NJ USA
[12] Univ Milan, Ca Granda Fdn IRCCS, Milan, Italy
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0927
引用
收藏
页码：383 / 383
页数：1
相关论文
共 50 条
  • [41] Role of Transient Elastography in Pediatric Transfusion Dependent Thalassemia Patients from Lower Socioeconomic Strata and its Correlation with Serum Ferritin: A Cross-Sectional Study
    Shambhavi
    Narayan, Kumar Shwetanshu
    Ghosh, Ananya
    Mitra, Olie
    Dubey, Pawan Kumar
    Manjari, Mrinal
    Sahay, Ujjawal
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024,
  • [42] Change in liver iron concentration (LIC), serum ferritin (SF) and labile plasma iron (LPI) over 1 year of deferasirox (Exjade®) therapy in a cohort of patients with MDS
    Greenberg, P. L.
    Koller, C. A.
    Glynos, T.
    Paley, C.
    Schiffer, C.
    LEUKEMIA RESEARCH, 2009, 33 : S120 - S120
  • [43] Liver Iron Content (LIC) in Adults with Sickle Cell Disease (SCD): Correlation with Serum Ferritin and Liver Enzymes Concentrations in Trasfusion Dependent (TD-SCD) and Non-Transfusion Dependent (NT-SCD) Patients
    Yassin, Mohamed
    Soliman, Ashraf
    De Sanctis, Vincenzo
    Nashwan, Abdelqadir
    Abusamaan, Sandra
    Moustafa, Abbas
    Kohla, Samah
    Soliman, Dina
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2017, 9
  • [44] Efficacy and Safety of Deferasirox (Exjade®) in Patients with Transfusion-Dependent Anemias: 1-Year Results from the Large, Prospective, Multicenter EPIC Study
    Cappellini, Maria Domenica
    El-Beshlawy, Amal
    Kattamis, Antonis
    Lee, Jong Wook
    Seymour, John F.
    Li, Chi-Kong
    Habr, Dany
    Domokos, Gabor
    Hmissi, Abdel
    Elafy, Mohsen Saleh
    BLOOD, 2008, 112 (11) : 1319 - 1319
  • [45] Association of Liver Iron Concentration Levels with Myocardial T2*Responses in Transfusion-Dependent Thalassemia Major Patients Treated with Deferasirox and Deferoxamine-Extension of Cordelia Study
    Pennell, Dudley J.
    Porter, John B.
    Piga, Antonio
    Han, Jackie
    Vorog, Alexander
    Aydinok, Yesim
    BLOOD, 2015, 126 (23)
  • [46] Insights into Relationships Between Serum Ferritin and Liver Iron Concentration Trends during 12 Months of Iron Chelation Therapy with Deferasirox - a Post-Hoc Analysis from the Epic Study
    Porter, John B.
    Elalfy, Mohsen
    Taher, Ali T.
    Chan, Lee Lee
    Lee, Szu-Hee
    Sutcharitchan, Pranee
    Aydinok, Yesim
    Chakravarty, Subhashish
    El-Ali, Ali
    El-Beshlawy, Amal
    BLOOD, 2014, 124 (21)
  • [47] Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study
    Taher, Ali T.
    Porter, John
    Viprakasit, Vip
    Kattamis, Antonis
    Chuncharunee, Suporn
    Sutcharitchan, Pranee
    Siritanaratkul, Noppadol
    Galanello, Renzo
    Karakas, Zeynep
    Lawniczek, Tomasz
    Ros, Jacqueline
    Zhang, Yiyun
    Habr, Dany
    Cappellini, Maria Domenica
    BLOOD, 2012, 120 (05) : 970 - 977
  • [48] LABILE PLASMA IRON LEVELS IN HEAVILY IRON-OVERLOADED PATIENTS WITH TRANSFUSION-DEPENDENT ANAEMIAS IN RESPONSE TO DEFERASIROX THERAPY: RESULTS FROM THE LARGE-SCALE, PROSPECTIVE 1-YEAR EPIC TRIAL
    Kattamis, A.
    El-Beshlawy, A.
    Seymour, J. F.
    Li, C. -K.
    Nick, H.
    Habr, D.
    Domokos, G.
    Roubert, B.
    Cappellini, M. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 75 - 75
  • [49] Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload
    Nolte, F.
    Hoechsmann, B.
    Giagounidis, A.
    Luebbert, M.
    Platzbecker, U.
    Haase, D.
    Lueck, A.
    Gattermann, N.
    Taupitz, M.
    Baier, M.
    Leismann, O.
    Junkes, A.
    Schumann, C.
    Hofmann, W. K.
    Schrezenmeier, H.
    ANNALS OF HEMATOLOGY, 2013, 92 (02) : 191 - 198
  • [50] Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload
    F. Nolte
    B. Höchsmann
    A. Giagounidis
    M. Lübbert
    U. Platzbecker
    D. Haase
    A. Lück
    N. Gattermann
    M. Taupitz
    M. Baier
    O. Leismann
    A. Junkes
    C. Schumann
    W. K. Hofmann
    H. Schrezenmeier
    Annals of Hematology, 2013, 92 : 191 - 198
12345